Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
GENEREX BIOTECHNOLOGY CORP (GNBT)
|
|
| Operating Efficiency |
|
|
|
|
Annual |
|
| In millions, except per share items | Jul-31-20 | Jul-31-19 | Jul-31-18 | Jul-31-17 | Jul-31-16 | Jul-31-15 | Jul-31-14 | Jul-31-13 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Turnover Ratios |
| Inventory turnover | 1.0 | 22.1 | 0.0 | 0.0 | | | | |
| Asset turnover | 0.1 | 0.2 | 0.1 | 0.0 | 2.7 | 0.3 | 0.0 | 0.0 |
| |
| Returns on Capital |
| ROIC (including intangibles) | -112.0% | -85.6% | 12.7% | | 8.2% | 54.8% | 75.3% | |
| ROE | 215.4% | -209.7% | 5.7% | | 6.6% | 43.0% | 72.2% | |
| ROA | -37.4% | -49.6% | -37.8% | | -2803.9% | -159.5% | -79.7% | |
| |
| Cash Conversion Cycle |
| Days sales outstanding | 22.6 | 2.1 | 17.4 | | 0.0 | 0.0 | | |
| Days payables outstanding | 828.3 | 116.1 | | | | | | |
| Days inventory outstanding | 467.2 | 32.0 | | | | | | |
| Cash conversion cycle | -338.4 | -81.9 | | | | 0.0 | | |
|